Browse by Title

Type here to filter the list

A
A Bayesian Framework to Summarize Negative Control Outcome Models Assessing the Comparability of Patients Initiating Migraine Preventive Medications

Shia T. Kent, PhD – Amgen ### 1991702###Presenting Author###Observational Research Senior Manager###Amgen###
Presenting Author: Shia T. Kent, PhD – Amgen
### @@@ David Pritchard, PhD, MS – Target RWE ### 1991703###Co-Author###Director, Data Management and Statistics###Target RWE###
Co-Author: David Pritchard, PhD, MS – Target RWE
### @@@ Sam S. Oh, PhD, MPH – Amgen ### 1991704###Co-Author###Observational Research Director###Amgen###
Co-Author: Sam S. Oh, PhD, MPH – Amgen
### @@@ Robert Urman, PhD – Amgen ### 1359004###Co-Author######Amgen###
Co-Author: Robert Urman, PhD – Amgen
### @@@ Paul Muntner, PhD, MHS – University of Alabama at Birmingham, Department of Epidemiology ### 1991705###Co-Author###Professor of Epidemiology and Associate Dean for Research###University of Alabama at Birmingham, Department of Epidemiology###
Co-Author: Paul Muntner, PhD, MHS – University of Alabama at Birmingham, Department of Epidemiology
### @@@ Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc. ### 1088313###Co-Author###Director of Observational Research###Amgen, Inc.###
Co-Author: Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc.
### she/her/hers @@@ M Alan Brookhart, PhD – Duke University ### 1991706###Co-Author###Professor###Duke University###
Co-Author: M Alan Brookhart, PhD – Duke University
###
A causal inference approach to evaluate the effect of Comprehensive Medication Reviews on all-cause mortality among Medicare beneficiaries

Ximena A. Oyarzun-Gonzalez, Ms, PhD, Pharm (she/her/hers) – Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Ohio, USA ### 1991369###Co-Author###Post Doctoral Scholar###Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Ohio, USA###
Co-Author: Ximena A. Oyarzun-Gonzalez, Ms, PhD, Pharm (she/her/hers) – Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Ohio, USA
### she/her/hers @@@ Erin L. Abner, MS, PhD – Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA ### 1358491###Co-Author###Associate Professor###Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA###
Co-Author: Erin L. Abner, MS, PhD – Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA
### @@@ Daniela C. Moga, MD, PhD (she/her/hers) – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA ### 1358307###Presenting Author###Associate Professor###Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA###
Presenting Author: Daniela C. Moga, MD, PhD (she/her/hers) – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA
### she/her/hers @@@ Anna M. Kucharska-Newton – Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, KY, USA ### 1358492###Co-Author######Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, KY, USA###
Co-Author: Anna M. Kucharska-Newton – Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, KY, USA
### @@@ Patricia R. Freeman, RPh, PhD – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, KY, USA ### 1656010###Co-Author###Professor###Department of Pharmacy Practice and Science, University of Kentucky, Lexington, KY, USA###
Co-Author: Patricia R. Freeman, RPh, PhD – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, KY, USA
### @@@ David W. Fardo, PhD – Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA ### 1659924###Co-Author###Professor###Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA###
Co-Author: David W. Fardo, PhD – Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA
###
A descriptive observational cohort study to assess effectiveness of risk minimization activities in baricitinib incident users treated for rheumatoid arthritis in Nordic countries

Mikkel Zöllner Ankarfeldt – Copenhagen Phase IV unit, (Phase4CPH), Department of Clinical Pharmacology, and Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark ### 1991668###Co-Author######Copenhagen Phase IV unit, (Phase4CPH), Department of Clinical Pharmacology, and Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark###
Co-Author: Mikkel Zöllner Ankarfeldt – Copenhagen Phase IV unit, (Phase4CPH), Department of Clinical Pharmacology, and Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark
### @@@ Aleksander Søltoft-Jensen – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg ### 1991669###Co-Author######Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg###
Co-Author: Aleksander Søltoft-Jensen – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg
### @@@ Karoline Doser – MedEngine. Helsinki. Finland ### 1991671###Co-Author######MedEngine. Helsinki. Finland###
Co-Author: Karoline Doser – MedEngine. Helsinki. Finland
### @@@ Eero Pukkala – Health Sciences Unit, Faculty of Social Sciences, 33014 Tampere University, Tampere, Finland ### 1991672###Co-Author######Health Sciences Unit, Faculty of Social Sciences, 33014 Tampere University, Tampere, Finland###
Co-Author: Eero Pukkala – Health Sciences Unit, Faculty of Social Sciences, 33014 Tampere University, Tampere, Finland
### @@@ Kristian Bolin – Department of Economics. Centre for Health Governance . University of Gothenburg. ### 1991673###Co-Author######Department of Economics. Centre for Health Governance . University of Gothenburg.###
Co-Author: Kristian Bolin – Department of Economics. Centre for Health Governance . University of Gothenburg.
### @@@ Janne Petersen, PhD – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg ### 1655556###Co-Author######Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg###
Co-Author: Janne Petersen, PhD – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg
### @@@ Espen Jimenez-Solem, MD, PhD – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg ### 1093553###Co-Author###Chief Physician###Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg###
Co-Author: Espen Jimenez-Solem, MD, PhD – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg
### @@@ Marius M. Flege, MD (he/him/his) – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg ### 1991670###Presenting Author###Pharmacoepidemiologist###Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg###
Presenting Author: Marius M. Flege, MD (he/him/his) – Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg
### he/him/his
A dynamic prognostic model for identifying vulnerable COVID-19 patients at high risk of rapid deterioration

Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital ### 1655514###Presenting Author###Research Specialist###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital###
Presenting Author: Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital
### @@@ Elvira D'Andrea – AbbVie ### 1991594###Co-Author######AbbVie###
Co-Author: Elvira D'Andrea – AbbVie
### @@@ William B. Feldman, MD, DPhil, MPH – Brigham and Women's Hospital ### 1991429###Co-Author###Instructor###Brigham and Women's Hospital###
Co-Author: William B. Feldman, MD, DPhil, MPH – Brigham and Women's Hospital
### @@@ Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School ### 1062580###Co-Author###Associate Professor###Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School
### she/her/hers @@@ Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1093509###Co-Author###Assistant Professor ###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Jun Liu – Brigham and Women’s Hospital ### 1659307###Co-Author######Brigham and Women’s Hospital###
Co-Author: Jun Liu – Brigham and Women’s Hospital
### @@@ Gregory Brill – Brigham and Women's Hospital ### 1655926###Co-Author###Programmer###Brigham and Women's Hospital###
Co-Author: Gregory Brill – Brigham and Women's Hospital
### @@@ Elyse C. Dicesare, BA – Brigham and Women's Hospital ### 1991353###Co-Author###Research Assistant###Brigham and Women's Hospital###
Co-Author: Elyse C. Dicesare, BA – Brigham and Women's Hospital
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital###
Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
###
A Meta-analysis of bias in Non-Small Cell Lung Cancer external control validation studies using PFS and real-world PFS endpoints

Sanaa Bahmane – F. Hoffmann-LaRoche Ltd ### 1991658###Co-Author######F. Hoffmann-LaRoche Ltd###
Co-Author: Sanaa Bahmane – F. Hoffmann-LaRoche Ltd
### @@@ Chris Harbron – F. Hoffmann-LaRoche Ltd ### 1359031###Co-Author######F. Hoffmann-LaRoche Ltd###
Co-Author: Chris Harbron – F. Hoffmann-LaRoche Ltd
### @@@ Devin Incerti – Entityrisk ### 1991659###Co-Author######Entityrisk###
Co-Author: Devin Incerti – Entityrisk
### @@@ Michael Bretscher, MSc, PhD – F. Hoffmann-LaRoche Ltd ### 1063200###Presenting Author###Principal Data Scientist###F. Hoffmann-LaRoche Ltd###
Presenting Author: Michael Bretscher, MSc, PhD – F. Hoffmann-LaRoche Ltd
###
A methodology study to evaluate external comparator arm study results versus randomised controlled trial results: metastatic Hormone-Sensitive Prostate Cancer case study

Wilhelmina E. Hoogendoorn, PhD – IQVIA ### 1397905###Presenting Author###Epidemiology Director###IQVIA###
Presenting Author: Wilhelmina E. Hoogendoorn, PhD – IQVIA
### @@@ Héctor Sanz – IQVIA ### 1991545###Co-Author######IQVIA###
Co-Author: Héctor Sanz – IQVIA
### @@@ Chantal Quinten – European Medicines Agency ### 1657379###Co-Author######European Medicines Agency###
Co-Author: Chantal Quinten – European Medicines Agency
### @@@ Joan Largent, MPH, PhD – IQVIA ### 1062674###Co-Author###Senior Director, Epidemiology###IQVIA###
Co-Author: Joan Largent, MPH, PhD – IQVIA
### @@@ Gerd Rippin, PhD – IQVIA ### 1991546###Co-Author###Senior Director, Biostatistics###IQVIA###
Co-Author: Gerd Rippin, PhD – IQVIA
###
A Pan-Formulary Analysis of the Association Between Community Pharmacy Dispensations with Local Area-Level Deprivation in England

Natalie Tikhonovsky, MSc – Health Analytics, Lane Clark & Peacock LLP ### 1991354###Co-Author###Analyst###Health Analytics, Lane Clark & Peacock LLP###
Co-Author: Natalie Tikhonovsky, MSc – Health Analytics, Lane Clark & Peacock LLP
### @@@ Florence Ma, MSc, MClinPharm, BCPS – Health Analytics, Lane Clark & Peacock LLP ### 1991355###Presenting Author###Analyst###Health Analytics, Lane Clark & Peacock LLP###
Presenting Author: Florence Ma, MSc, MClinPharm, BCPS – Health Analytics, Lane Clark & Peacock LLP
### @@@ Danielle E. Robinson, PhD (she/her/hers) – Health Analytics, Lane Clark & Peacock LLP ### 1655390###Co-Author###Epidemiologist###Health Analytics, Lane Clark & Peacock LLP###
Co-Author: Danielle E. Robinson, PhD (she/her/hers) – Health Analytics, Lane Clark & Peacock LLP
### she/her/hers @@@ Jonathan Pearson-Stuttard, BMBCh, PhD, FRSPH, FFPH – Health Analytics, Lane Clark & Peacock LLP ### 1655397###Co-Author######Health Analytics, Lane Clark & Peacock LLP###
Co-Author: Jonathan Pearson-Stuttard, BMBCh, PhD, FRSPH, FFPH – Health Analytics, Lane Clark & Peacock LLP
### @@@ Benjamin D Bray – Health Analytics, Lane Clark & Peacock LLP ### 1655391###Co-Author###Principal###Health Analytics, Lane Clark & Peacock LLP###
Co-Author: Benjamin D Bray – Health Analytics, Lane Clark & Peacock LLP
###
A pilot evaluation of switchback from biosimilars to originator-biologics in the Veterans Affairs population: a signal of biosimilar failure?

Kelly M. Bryan, PharmD (she/her/hers) – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs ### 1991595###Presenting Author###Medication Safety and Pharmacy Outcomes Fellow###Veterans Affairs Center for Medication Safety, Department of Veterans Affairs###
Presenting Author: Kelly M. Bryan, PharmD (she/her/hers) – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs
### she/her/hers @@@ Qoua L. Her, PharmD, MSc – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1659732###Co-Author###Graduate Student###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###
Co-Author: Qoua L. Her, PharmD, MSc – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Diane Dong, MPH, MS – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs ### 1655510###Co-Author######Veterans Affairs Center for Medication Safety, Department of Veterans Affairs###
Co-Author: Diane Dong, MPH, MS – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs
### @@@ Rong Jiang, MS – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs ### 1991597###Co-Author######Veterans Affairs Center for Medication Safety, Department of Veterans Affairs###
Co-Author: Rong Jiang, MS – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs
### @@@ Jennifer Martin, Pharm.D., BCPP – Veterans Affairs Pharmacy Benefits Management ### 1657519###Co-Author###Deputy Chief Consultant, PBM###Veterans Affairs Pharmacy Benefits Management###
Co-Author: Jennifer Martin, Pharm.D., BCPP – Veterans Affairs Pharmacy Benefits Management
### @@@ Fran Cunningham, PharmD – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs ### 1655509###Co-Author###Director, Center for Medication Safety###Veterans Affairs Center for Medication Safety, Department of Veterans Affairs###
Co-Author: Fran Cunningham, PharmD – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs
###
A Tour of Informatics: From Prediction to Prevalence

Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Co-Moderator###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###
Co-Moderator: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics ### 1062823###Co-Moderator###Assistant Professor###BWH Div of Pharmacoepidemiology and Pharmacoeconomics###
Co-Moderator: Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
###
Accounting for treatment switching by pairwise censoring: Is this needed, sufficient to mitigate attrition bias, or should more advanced methodology be used?

Sudhir Venkatesan, MPH, PhD – Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK; Department of Medical Statistics ### 1658797###Presenting Author###Director###Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK; Department of Medical Statistics###
Presenting Author: Sudhir Venkatesan, MPH, PhD – Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK; Department of Medical Statistics
### @@@ Jonatan Hedberg – Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden ### 1991547###Co-Author######Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden###
Co-Author: Jonatan Hedberg – Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden
### @@@ Carla A. Talarico, PhD – Epidemiology, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca ### 1991256###Co-Author######Epidemiology, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca###
Co-Author: Carla A. Talarico, PhD – Epidemiology, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca
### @@@ Mario Ouwens, PhD – Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Mölndal, Sweden ### 1358658###Co-Author######Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Mölndal, Sweden###
Co-Author: Mario Ouwens, PhD – Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Mölndal, Sweden
###
Active vaccine safety surveillance utilizing administrative data: evaluating the use of open + closed claims vs. closed claims alone

Deesha A. Patel, MS (she/her/hers) – Aetion, Inc. ### 1655851###Presenting Author###Senior Scientist###Aetion, Inc.###
Presenting Author: Deesha A. Patel, MS (she/her/hers) – Aetion, Inc.
### she/her/hers @@@ Victoria Cooley – Aetion, Inc. ### 1991444###Co-Author######Aetion, Inc.###
Co-Author: Victoria Cooley – Aetion, Inc.
### @@@ Christopher Bush, MPH (he/him/his) – Aetion, Inc. ### 1655850###Co-Author###Sr. Scientist ###Aetion, Inc.###
Co-Author: Christopher Bush, MPH (he/him/his) – Aetion, Inc.
### he/him/his @@@ Neloufar Rahai, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1991443###Co-Author###Senior Scientist###Aetion, Inc.###
Co-Author: Neloufar Rahai, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hers @@@ Katherine E. Mues – Aetion, Inc. ### 1655854###Co-Author######Aetion, Inc.###
Co-Author: Katherine E. Mues – Aetion, Inc.
### @@@ Rebecca Taylor – Aetion, Inc. ### 1991448###Co-Author######Aetion, Inc.###
Co-Author: Rebecca Taylor – Aetion, Inc.
### @@@ Sahar Syed – Aetion, Inc. ### 1397917###Co-Author###Scientific Analyst###Aetion, Inc.###
Co-Author: Sahar Syed – Aetion, Inc.
### @@@ Shaina Desai, MPH – Aetion, Inc. ### 1991445###Co-Author######Aetion, Inc.###
Co-Author: Shaina Desai, MPH – Aetion, Inc.
### @@@ Pippa Hodgkins – Aetion, Inc. ### 1991447###Co-Author######Aetion, Inc.###
Co-Author: Pippa Hodgkins – Aetion, Inc.
### @@@ Brent Arakaki – Aetion, Inc. ### 1991446###Co-Author######Aetion, Inc.###
Co-Author: Brent Arakaki – Aetion, Inc.
### @@@ Priyadarshani Dharia, PhD, MD, MPH – Moderna, Inc. ### 1655853###Co-Author###Director, Global Safety Epidemiologist###Moderna, Inc.###
Co-Author: Priyadarshani Dharia, PhD, MD, MPH – Moderna, Inc.
### @@@ David Martin, MD, MPH – Moderna, Inc. ### 1360465###Co-Author###Vice President, Clinical Safety and Risk Management###Moderna, Inc.###
Co-Author: David Martin, MD, MPH – Moderna, Inc.
### @@@ Daina Esposito, MPH, PhD (she/her/hers) – Moderna, Inc. ### 1655290###Co-Author###Sr. Director, Global Safety Epidemiologist###Moderna, Inc.###
Co-Author: Daina Esposito, MPH, PhD (she/her/hers) – Moderna, Inc.
### she/her/hers
Adherence to Medication

Jacqueline G. Hugtenburg – University of Curacao and VU University Medical Center Amsterdam ### 1658657###Lead Speaker###Professor of Health Promotion and Disease Prevention and Associate Professor of Pharmacoepidemiology###University of Curacao and VU University Medical Center Amsterdam###
Lead Speaker: Jacqueline G. Hugtenburg – University of Curacao and VU University Medical Center Amsterdam
### @@@ Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics ### 1062823###Speaker###Assistant Professor###BWH Div of Pharmacoepidemiology and Pharmacoeconomics###
Speaker: Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Robert Gross, MD, MSCE, FISPE – University of Pennsylvania ### 1086967###Speaker###Professor of Medicine (ID) and Epidemiology###University of Pennsylvania###
Speaker: Robert Gross, MD, MSCE, FISPE – University of Pennsylvania
###
Adjusting for unmeasured confounding bias in the Statin Treatment OPtions during vaccination against Flu (STOPFlu) study: an application of the Prior Event Rate Ratio Pairwise method

Adam J. Streeter, PhD – University of Munster, Germany ### 1660053###Presenting Author###Biostatistician###University of Munster, Germany###
Presenting Author: Adam J. Streeter, PhD – University of Munster, Germany
### @@@ William Henley – University of Exeter ### 1659798###Co-Author######University of Exeter###
Co-Author: William Henley – University of Exeter
###
Advanced Drug Utilization Research: The Conduct of Real-World Drug Utilization Studies: Development And Evaluation of Interventions to Improve the Quality of Medication Use

Petra Denig, PharmD, PhD, FISPE – University Medical Center Groningen ### 1086986###Lead Speaker###PhD, FISPE###University Medical Center Groningen###
Lead Speaker: Petra Denig, PharmD, PhD, FISPE – University Medical Center Groningen
### @@@ Katja Taxis, MSc, PhD, FISPE – University of Groningen ### 1086972###Speaker###Professor###University of Groningen###
Speaker: Katja Taxis, MSc, PhD, FISPE – University of Groningen
### @@@ Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto ### 1062862###Speaker###Assistant Professor###University of Toronto###
Speaker: Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto
### @@@ Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet ### 1358115###Speaker###Assistant professor###Syddansk Universitet###
Speaker: Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet
###
Advanced Methods I: Evidence Synthesis Methods, Living Methods, and Applied Examples in Healthcare Research

Nivantha Naidoo, MBChB, DipPEC, MPH, MSc CER (she/her/hers) – Cerner Enviza an Oracle company ### 2016382###Lead Speaker###Associate Principal, Real-World Evidence###Cerner Enviza an Oracle company###
Lead Speaker: Nivantha Naidoo, MBChB, DipPEC, MPH, MSc CER (she/her/hers) – Cerner Enviza an Oracle company
### she/her/hers @@@ Deborah Layton, PhD, FISPE – PEPI Consultancy Limited ### 1656012###Moderator###Director###PEPI Consultancy Limited###
Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
### @@@ Samantha Lane, MSc, PgD (she/her/hers) – Institute of Pharmacovigilance Sciences, Drug Safety Research Unit ### 1062612###Speaker###Head of Research###Institute of Pharmacovigilance Sciences, Drug Safety Research Unit###
Speaker: Samantha Lane, MSc, PgD (she/her/hers) – Institute of Pharmacovigilance Sciences, Drug Safety Research Unit
### she/her/hers @@@ Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc. ### 1991390###Speaker###Executive Director, Head of Epidemiology and Risk Management Operation###BeiGene USA, Inc.###
Speaker: Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc.
### he/him/his
Advanced Methods II: How to Make Sure Immortal Time Never Happens

Miguel A. Hernan – CAUSALab, Harvard T.H. Chan School of Public Health ### 1360646###Lead Speaker######CAUSALab, Harvard T.H. Chan School of Public Health###
Lead Speaker: Miguel A. Hernan – CAUSALab, Harvard T.H. Chan School of Public Health
### @@@ Deborah Layton, PhD, FISPE – PEPI Consultancy Limited ### 1656012###Moderator###Director###PEPI Consultancy Limited###
Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
### @@@ Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions ### 1062596###Speaker###Director, Epidemiology###RTI Health Solutions###
Speaker: Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions
###
Ambient Heat, Exogenous Insulin, and Risk of Hypoglycemia Among Older Medicare Beneficiaries with Diabetes

Aayush Visaria, MD, MPH (he/him/his) – Rutgers Robert Wood Johnson Medical School ### 1655924###Co-Author###Internal Medicine PGY-2###Rutgers Robert Wood Johnson Medical School###
Co-Author: Aayush Visaria, MD, MPH (he/him/his) – Rutgers Robert Wood Johnson Medical School
### he/him/his @@@ Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ ### 1302720###Presenting Author###Professor of Medicine and Epidemiology###Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ###
Presenting Author: Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
###
An analytic method to weight longitudinal treatment patterns for visualization with Sankey diagrams

Catherine Wiener, MS (she/her/hers) – University of North Carolina at Chapel Hill ### 1991528###Presenting Author###PhD Student###University of North Carolina at Chapel Hill###
Presenting Author: Catherine Wiener, MS (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ M Alan Brookhart, PhD – Duke University ### 1991706###Co-Author###Professor###Duke University###
Co-Author: M Alan Brookhart, PhD – Duke University
###
Annual Meeting of ISPE Members & Awards Ceremony

Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University ### 1046831###Keynote Speaker###Professor and Director###Center for Pharmacoepidemiology and Treatment Science, Rutgers University###
Keynote Speaker: Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University
### he/him/his @@@ Caitlin Knox, PhD MPH (she/her/hers) – Regeneron Pharmaceuticals, Inc. ### 1360272###Keynote Speaker###Sr Dir, Pharmacoepidemiology###Regeneron Pharmaceuticals, Inc.###
Keynote Speaker: Caitlin Knox, PhD MPH (she/her/hers) – Regeneron Pharmaceuticals, Inc.
### she/her/hers @@@ James Vrac, CAE – International Society for Pharmacoepidemiology ### 1668288###Keynote Speaker###Executive Secretary###International Society for Pharmacoepidemiology###
Keynote Speaker: James Vrac, CAE – International Society for Pharmacoepidemiology
###
Antidepressant Treatment Initiation Among Children with Long COVID

Phuong TM Tran, MPH – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1658122###Presenting Author###PhD student###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###
Presenting Author: Phuong TM Tran, MPH – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
### @@@ Alejandro Amill-Rosario, PhD, MPH – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1655866###Co-Author###Research Associate###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###
Co-Author: Alejandro Amill-Rosario, PhD, MPH – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
### @@@ Susan dosReis, PhD – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1359191###Co-Author###Professor, Department of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###
Co-Author: Susan dosReis, PhD – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
###
Antiseizure Medication During Pregnancy and Offspring Neurodevelopmental Outcomes: A Study of Two Cohorts from the UK and Sweden

Viktor H. Ahlqvist, MMsc – Karolinska Institutet ### 1658786###Presenting Author###PhD Student###Karolinska Institutet###
Presenting Author: Viktor H. Ahlqvist, MMsc – Karolinska Institutet
### @@@ Paul Madley-Dowd – University of Bristol ### 1658787###Co-Author######University of Bristol###
Co-Author: Paul Madley-Dowd – University of Bristol
### @@@ Harriet Forbes – London School of Hygiene and Tropical Medicine ### 1093522###Co-Author######London School of Hygiene and Tropical Medicine###
Co-Author: Harriet Forbes – London School of Hygiene and Tropical Medicine
### @@@ Jessica E. Rast, PhD, MPH – Drexel University ### 1658789###Co-Author######Drexel University###
Co-Author: Jessica E. Rast, PhD, MPH – Drexel University
### @@@ Caichen Zhong – Drexel University ### 1659401###Co-Author######Drexel University###
Co-Author: Caichen Zhong – Drexel University
### @@@ Michael Lundberg – Karolinska Institutet ### 1658790###Co-Author######Karolinska Institutet###
Co-Author: Michael Lundberg – Karolinska Institutet
### @@@ Ciarrah-Jane S. Barry, Bsc – University of Bristol ### 1900244###Co-Author###PhD student###University of Bristol###
Co-Author: Ciarrah-Jane S. Barry, Bsc – University of Bristol
### @@@ Florence Z. Martin, MSc (she/her/hers) – University of Bristol ### 1991287###Co-Author###PhD Student###University of Bristol###
Co-Author: Florence Z. Martin, MSc (she/her/hers) – University of Bristol
### she/her/hers @@@ Lars Torbjorn Tomson, MD, PhD – Karolinska Institutet ### 1360038###Co-Author######Karolinska Institutet###
Co-Author: Lars Torbjorn Tomson, MD, PhD – Karolinska Institutet
### @@@ Daniel Berglind – Karolinska Institutet ### 1658792###Co-Author######Karolinska Institutet###
Co-Author: Daniel Berglind – Karolinska Institutet
### @@@ Neil M. Davies, PhD – University of Bristol ### 1658718###Co-Author###Professor of Medical Statistics###University of Bristol###
Co-Author: Neil M. Davies, PhD – University of Bristol
### @@@ Kristen Lyall – Drexel University ### 1991488###Co-Author######Drexel University###
Co-Author: Kristen Lyall – Drexel University
### @@@ Dheeraj Rai – University of Bristol ### 1658793###Co-Author######University of Bristol###
Co-Author: Dheeraj Rai – University of Bristol
### @@@ Cecilia Magnusson – Karolinska Institutet ### 1658794###Co-Author######Karolinska Institutet###
Co-Author: Cecilia Magnusson – Karolinska Institutet
### @@@ Brian K. Lee – Drexel University School of Public Health ### 1658795###Co-Author######Drexel University School of Public Health###
Co-Author: Brian K. Lee – Drexel University School of Public Health
###
Antithyroid Drug Use Before and During Pregnancy: Assessment of Switching Patterns and Changes Over Time

Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062583###Presenting Author###Senior scientist###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Presenting Author: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers @@@ Bianca Kollhorst – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1991220###Co-Author######Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Co-Author: Bianca Kollhorst – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### @@@ Ulrike Haug, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062658###Co-Author###Prof. Dr. sc. hum.###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Co-Author: Ulrike Haug, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS
###
Application of new signal detection methods to EUROmediCAT data: Bayesian Confidence Propagation Neural Network-Biclustering (BCPNN-Bic) and BCPNN-Bicluster-Bayesian Hierarchical Modelling (BBBHM)

Hannah Johnson, MSc (she/her/hers) – St George's, University of London ### 1991301###Presenting Author###PhD Researcher###St George's, University of London###
Presenting Author: Hannah Johnson, MSc (she/her/hers) – St George's, University of London
### she/her/hers @@@ Joan K. Morris – St George's, University of London, London ### 1900343###Co-Author###Professor###St George's, University of London, London###
Co-Author: Joan K. Morris – St George's, University of London, London
###
Applied Methods for Evaluating Effectiveness

Mugdha Gokhale, PhD – Pfizer ### 1088166###Co-Moderator###Director, Value & Evidence###Pfizer###
Co-Moderator: Mugdha Gokhale, PhD – Pfizer
### @@@ Kenneth KC Man, MPH, PhD, FRSPH (he/him/his) – UCL School of Pharmacy, University College London, London, United Kingdom ### 1358158###Co-Moderator###Lecturer in Pharmacoepidemiology and Medication Safety###UCL School of Pharmacy, University College London, London, United Kingdom###
Co-Moderator: Kenneth KC Man, MPH, PhD, FRSPH (he/him/his) – UCL School of Pharmacy, University College London, London, United Kingdom
### he/him/his
Applied Sensitivity Analyses in Pharmacoepidemiology Database Studies

Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1046819###Lead Speaker###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###
Lead Speaker: Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### he/him/his @@@ Jeremy A. Rassen, ScD, FISPE – Aetion ### 1062955###Speaker###Co-founder and President###Aetion###
Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion
### @@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1360328###Speaker###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###
Speaker: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### @@@ Elizabeth M. Garry, MPH, PhD – Aetion, Inc. ### 1062756###Speaker###Head of Scientific Research###Aetion, Inc.###
Speaker: Elizabeth M. Garry, MPH, PhD – Aetion, Inc.
###
Approach to standardised drug utilisation analyses in DARWIN EU©

Annika M. Jödicke, PhD (she/her/hers) – University of Oxford ### 1358980###Presenting Author###Senior Researcher in Pharmacoepidemiology###University of Oxford###
Presenting Author: Annika M. Jödicke, PhD (she/her/hers) – University of Oxford
### she/her/hers @@@ Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1360474###Co-Author###Senior Researcher in Public Health and Epidemiology###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Co-Author: Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1659148###Co-Author###Senior Data Scientist###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Co-Author: Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### he/him/his @@@ Edward Burn, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358374###Co-Author###Senior Researcher###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Co-Author: Edward Burn, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Maria de Ridder – Erasmus University Medical Center ### 1360078###Co-Author######Erasmus University Medical Center###
Co-Author: Maria de Ridder – Erasmus University Medical Center
### @@@ Peter R. Rijnbeek, PhD – Department of Medical Informatics, Erasmus University Medical Center ### 1094832###Co-Author###Professor Medical Informatics###Department of Medical Informatics, Erasmus University Medical Center###
Co-Author: Peter R. Rijnbeek, PhD – Department of Medical Informatics, Erasmus University Medical Center
### @@@ Katia M. Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC University ### 1092267###Co-Author###Associate Professor###Department of Medical Informatics, Erasmus MC University###
Co-Author: Katia M. Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC University
### she/her/hers @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###
Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his
Approaches to the Description of Patterns of Care after Colitis Diagnosis in Melanoma Patients Treated with Immune Checkpoint Inhibitors (ICIs)

Xianying Pan, MS – Bristol Myers Squibb ### 1657855###Presenting Author###Epidemiologist###Bristol Myers Squibb###
Presenting Author: Xianying Pan, MS – Bristol Myers Squibb
### @@@ Vishal Kulkarni – Mu Sigma ### 1991431###Co-Author######Mu Sigma###
Co-Author: Vishal Kulkarni – Mu Sigma
### @@@ Raminder Pathak – Bristol Myers Squibb ### 1991432###Co-Author######Bristol Myers Squibb###
Co-Author: Raminder Pathak – Bristol Myers Squibb
### @@@ Stefano Monda – Bristol Myers Squibb ### 1991433###Co-Author######Bristol Myers Squibb###
Co-Author: Stefano Monda – Bristol Myers Squibb
### @@@ Imran Hasan – Bristol Myers Squibb ### 1991434###Co-Author######Bristol Myers Squibb###
Co-Author: Imran Hasan – Bristol Myers Squibb
###
Are Major Congenital Malformations (MCMs) Identifiable Among Claims for Non-Live Births?

Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology ### 1659086###Presenting Author###Senior Epidemiologist###Optum Epidemiology###
Presenting Author: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hers @@@ Michael C. Doherty, MS – Optum Epidemiology ### 1358137###Co-Author###Principal Epidemiology Analyst###Optum Epidemiology###
Co-Author: Michael C. Doherty, MS – Optum Epidemiology
### @@@ Rishav Singla – Optum Global Solutions ### 1991281###Co-Author###Data Analyst###Optum Global Solutions###
Co-Author: Rishav Singla – Optum Global Solutions
### @@@ John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology ### 1046832###Co-Author###Chief Scientific Officer###Optum Epidemiology###
Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology
###
Assessing comparability of osteoporosis treatment groups using real world healthcare data from the UK and Denmark: evaluating propensity score and negative control outcome methods to address confounding by indication

Eng Hooi (Cheryl) Tan, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358989###Presenting Author###Pharmacoepidemiologist###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Presenting Author: Eng Hooi (Cheryl) Tan, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Trishna Rathod-Mistry, PhD – University of Oxford ### 1655337###Co-Author######University of Oxford###
Co-Author: Trishna Rathod-Mistry, PhD – University of Oxford
### @@@ Victoria Y. Strauss, PhD – Boehringer Ingelheim Pharma GmbH & Co. KG ### 1088161###Co-Author###Director TA Methodology Statistician RWE ###Boehringer Ingelheim Pharma GmbH & Co. KG###
Co-Author: Victoria Y. Strauss, PhD – Boehringer Ingelheim Pharma GmbH & Co. KG
### @@@ James O'Kelly, PhD – Amgen Ltd ### 1655484###Co-Author######Amgen Ltd###
Co-Author: James O'Kelly, PhD – Amgen Ltd
### @@@ Francesco Giorgianni – Amgen Ltd ### 1993509###Co-Author######Amgen Ltd###
Co-Author: Francesco Giorgianni – Amgen Ltd
### @@@ Richard Baxter – Amgen Ltd ### 1993510###Co-Author######Amgen Ltd###
Co-Author: Richard Baxter – Amgen Ltd
### @@@ Alma B. Pedersen, PhD – Department of Clinical Epidemiology Aarhus University and Department of Clinical Medicine Aarhus University Hospital ### 1062926###Co-Author###Professor###Department of Clinical Epidemiology Aarhus University and Department of Clinical Medicine Aarhus University Hospital###
Co-Author: Alma B. Pedersen, PhD – Department of Clinical Epidemiology Aarhus University and Department of Clinical Medicine Aarhus University Hospital
### @@@ Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1062544###Co-Author######Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###
Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his
Assessing the performance of group-based trajectory modelling method to discover patterns of medication adherence

Awa Diop, PhD – Cytel ### 1360376###Co-Author###Senior Research Consultant###Cytel###
Co-Author: Awa Diop, PhD – Cytel
### @@@ Alind Gupta, PhD – Cytel ### 1991513###Presenting Author###Research Principal###Cytel###
Presenting Author: Alind Gupta, PhD – Cytel
### @@@ louis Dron – Cytel ### 1723579###Co-Author######Cytel###
Co-Author: louis Dron – Cytel
### @@@ Sabrina Mueller, MSc – Cytel ### 1660161###Co-Author###Research Principal, Senior Director###Cytel###
Co-Author: Sabrina Mueller, MSc – Cytel
### @@@ Gerald Smith – Cytel ### 1991514###Co-Author######Cytel###
Co-Author: Gerald Smith – Cytel
###
Assessment of Neurological and Immunological Adverse Events Following Childhood Pneumococcal Vaccination: a Population-Based Self-Controlled Risk Interval Analysis

Ju Hwan Kim, PharmD, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea ### 1302812###Presenting Author###Post-doctoral researcher###School of Pharmacy, Sungkyunkwan University, South Korea###
Presenting Author: Ju Hwan Kim, PharmD, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea
### he/him/his @@@ Dongwon Yoon, PharmD, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea ### 1063238###Co-Author###Post-doctoral researcher###School of Pharmacy, Sungkyunkwan University, South Korea###
Co-Author: Dongwon Yoon, PharmD, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea
### he/him/his @@@ Hyesung Lee, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea ### 1063055###Co-Author###Research Professor###School of Pharmacy, Sungkyunkwan University, South Korea###
Co-Author: Hyesung Lee, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea
### he/him/his @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###
Assessment of the Effectiveness of Risk Evaluation and Mitigation Strategy for the Prevention of Fetal Exposure to Phentermine-Topiramate Using Two Large Nationwide Cohorts

Yanmin Zhu, MS, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1063282###Presenting Author###Instructor in Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###
Presenting Author: Yanmin Zhu, MS, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### @@@ Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University ### 1093997###Co-Author###Professor of Epidemiology###Harvard University###
Co-Author: Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University
### @@@ Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital ### 1655514###Co-Author###Research Specialist###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital###
Co-Author: Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital
### @@@ Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School ### 1655839###Co-Author###Assistant Professor###Brigham and Women's Hospital and Harvard Medical School###
Co-Author: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Ameet Sarpatwari, PHD JD (he/him/his) – Brigham & Womens Hospital/Harvard Medical School ### 1360165###Co-Author###Assistant Professor of Medicine###Brigham & Womens Hospital/Harvard Medical School###
Co-Author: Ameet Sarpatwari, PHD JD (he/him/his) – Brigham & Womens Hospital/Harvard Medical School
### he/him/his @@@ Mufaddal Mahesri, MD, MPH (he/him/his) – Brigham and Women's Hospital ### 1655868###Co-Author###Senior Research Specialist###Brigham and Women's Hospital###
Co-Author: Mufaddal Mahesri, MD, MPH (he/him/his) – Brigham and Women's Hospital
### he/him/his @@@ Elyse C. Dicesare, BA – Brigham and Women's Hospital ### 1991353###Co-Author###Research Assistant###Brigham and Women's Hospital###
Co-Author: Elyse C. Dicesare, BA – Brigham and Women's Hospital
### @@@ Seanna Vine – Brigham and Women's Hospital ### 1397958###Co-Author######Brigham and Women's Hospital###
Co-Author: Seanna Vine – Brigham and Women's Hospital
### @@@ Helen Mogun – Brigham and Women's Hospital ### 1359929###Co-Author######Brigham and Women's Hospital###
Co-Author: Helen Mogun – Brigham and Women's Hospital
### @@@ Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School ### 1359931###Co-Author######Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
###
Association between angiotensin receptor blocker drug recalls and adverse clinical outcomes in patients with heart failure

Joshua Devine, PharmD, PhD (he/him/his) – Department of Public Health, Des Moines University ### 1991631###Co-Author###Assistant Professor###Department of Public Health, Des Moines University###
Co-Author: Joshua Devine, PharmD, PhD (he/him/his) – Department of Public Health, Des Moines University
### he/him/his @@@ Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto ### 1062862###Co-Author###Assistant Professor###University of Toronto###
Co-Author: Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto
### @@@ Nandita Mukhopadhyay, PhD – University of Pittsburgh ### 1991630###Co-Author###Programmer/Data Analyst###University of Pittsburgh###
Co-Author: Nandita Mukhopadhyay, PhD – University of Pittsburgh
### @@@ Inmaculada Hernandez, PharmD, PhD – Division of Clinical Pharmacy, University of California San Diego ### 1658462###Co-Author###Associate Professor###Division of Clinical Pharmacy, University of California San Diego###
Co-Author: Inmaculada Hernandez, PharmD, PhD – Division of Clinical Pharmacy, University of California San Diego
### @@@ Scott D. Rothenberger, PhD – Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA ### 1358097###Co-Author###Assistant Professor###Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA###
Co-Author: Scott D. Rothenberger, PhD – Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
### @@@ Katherine Callaway Kim, MPH – Department of Medicine, Division of General Internal Medicine, University of Pittsburgh School of MedicineDepartment of Health Policy and Management, University of Pittsburgh School of Public Health ### 1655370###Co-Author###Graduate Student###Department of Medicine, Division of General Internal Medicine, University of Pittsburgh School of MedicineDepartment of Health Policy and Management, University of Pittsburgh School of Public Health###
Co-Author: Katherine Callaway Kim, MPH – Department of Medicine, Division of General Internal Medicine, University of Pittsburgh School of MedicineDepartment of Health Policy and Management, University of Pittsburgh School of Public Health
### @@@ Katie Suda, PharmD, M.S., FCCP (she/her/hers) – University of Pittsburgh ### 1360024###Presenting Author###Professor###University of Pittsburgh###
Presenting Author: Katie Suda, PharmD, M.S., FCCP (she/her/hers) – University of Pittsburgh
### she/her/hers
Association between antihypertensive medication initiation and risk of fractures among older adults in VA long-term care facilities

Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ ### 1655382###Presenting Author###Assistant Professor of Pharmacy and Epidemiology###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ###
Presenting Author: Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ
### @@@ Yongmei Li – Stanford University ### 1991691###Co-Author######Stanford University###
Co-Author: Yongmei Li – Stanford University
### @@@ Michelle Odden – Stanford University ### 1655753###Co-Author######Stanford University###
Co-Author: Michelle Odden – Stanford University
###
Association between COVID-19 vaccination and healthcare contacts for menstrual disturbance and pre- and post-menopausal bleeding – a nationwide cohort study of 3 million Swedish women

Yiyi Xu, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1991226###Co-Author###Researcher###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Co-Author: Yiyi Xu, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Rickard Ljung – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden ### 1657798###Co-Author######Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden###
Co-Author: Rickard Ljung – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden
### @@@ Anders Sundström, PhD (he/him/his) – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden ### 1991227###Co-Author###Pharmacoepidemiologist###Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden###
Co-Author: Anders Sundström, PhD (he/him/his) – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden
### he/him/his @@@ Susannah Leach – Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1659122###Co-Author######Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Co-Author: Susannah Leach – Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Ebba Hallberg – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden ### 1991228###Co-Author######Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden###
Co-Author: Ebba Hallberg – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden
### @@@ Maria Bygdell – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1991229###Co-Author######School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Co-Author: Maria Bygdell – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Maria Larsson – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden ### 1991230###Co-Author######Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden###
Co-Author: Maria Larsson – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden
### @@@ Veronica Arthurson – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden ### 1991231###Co-Author######Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden###
Co-Author: Veronica Arthurson – Division of Use and Information, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden
### @@@ Magnus Gisslen – Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1358955###Co-Author######Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Co-Author: Magnus Gisslen – Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Rolf Gedeborg – Division of Licensing, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden ### 1991232###Co-Author######Division of Licensing, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden###
Co-Author: Rolf Gedeborg – Division of Licensing, Swedish Medical Products Agency, PO Box 26, 751 03 Uppsala, Sweden
### @@@ Fredrik Nyberg, MD, PhD, FISPE – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1358933###Presenting Author###Prof. of Register Epidemiology###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Presenting Author: Fredrik Nyberg, MD, PhD, FISPE – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
###
Association between Dietary Supplement Use and Mortality among US Adults with Diabetes: a Longitudinal Cohort Study

Rong Hua, Mphil – School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong ### 1991456###Presenting Author###PhD student###School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong###
Presenting Author: Rong Hua, Mphil – School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
### @@@ Chun Sing Lam, BPharm – School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong ### 1991457###Co-Author######School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong###
Co-Author: Chun Sing Lam, BPharm – School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
### @@@ Natural Chu – Department of Medicine and Therapeutics, The Chinese University of Hong Kong ### 1991655###Co-Author######Department of Medicine and Therapeutics, The Chinese University of Hong Kong###
Co-Author: Natural Chu – Department of Medicine and Therapeutics, The Chinese University of Hong Kong
### @@@ Aimin Yang – Department of Medicine and Therapeutics, The Chinese University of Hong Kong ### 1991656###Co-Author######Department of Medicine and Therapeutics, The Chinese University of Hong Kong###
Co-Author: Aimin Yang – Department of Medicine and Therapeutics, The Chinese University of Hong Kong
### @@@ Elaine Chow – Department of Medicine and Therapeutics, The Chinese University of Hong Kong ### 1991657###Co-Author######Department of Medicine and Therapeutics, The Chinese University of Hong Kong###
Co-Author: Elaine Chow – Department of Medicine and Therapeutics, The Chinese University of Hong Kong
### @@@ Yin Ting Cheung, PhD – School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong ### 1358352###Co-Author###Assistant Professor###School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong###
Co-Author: Yin Ting Cheung, PhD – School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
###
Association between gabapentinoids and the risk of severe exacerbations in patients with chronic obstructive pulmonary disease

Alvi A. Rahman, MSc – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1090308###Presenting Author###PhD Candidate###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###
Presenting Author: Alvi A. Rahman, MSc – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### @@@ Sophie Dell'Aniello – Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada ### 1359036###Co-Author######Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada###
Co-Author: Sophie Dell'Aniello – Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada
### @@@ Erica E.M. Moodie – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1397943###Co-Author###Full Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###
Co-Author: Erica E.M. Moodie – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### @@@ Madeleine Durand – Department of Medicine, Université de Montréal, Montreal, QC, Canada ### 1359486###Co-Author###Assistant Clinical Professor###Department of Medicine, Université de Montréal, Montreal, QC, Canada###
Co-Author: Madeleine Durand – Department of Medicine, Université de Montréal, Montreal, QC, Canada
### @@@ Janie Coulombe, PhD – Department of Mathematics and Statistics, Université de Montréal, Montreal, QC, Canada ### 1991352###Co-Author###Assistant Professor###Department of Mathematics and Statistics, Université de Montréal, Montreal, QC, Canada###
Co-Author: Janie Coulombe, PhD – Department of Mathematics and Statistics, Université de Montréal, Montreal, QC, Canada
### @@@ Jean-François Boivin – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1397945###Co-Author###Full Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###
Co-Author: Jean-François Boivin – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### @@@ Pierre Ernst – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1655844###Co-Author######Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###
Co-Author: Pierre Ernst – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### @@@ Christel Renoux, MD PhD – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358292###Co-Author###Associate Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###
Co-Author: Christel Renoux, MD PhD – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
###
Association of Anticholinergic Burden and Risk of Pneumonia in Aged People

Avery Shuei He Yang – School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1658473###Presenting Author###Research Associate###School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Presenting Author: Avery Shuei He Yang – School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### @@@ Xin-Yu Fan Jiang – School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1991620###Co-Author######School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Xin-Yu Fan Jiang – School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### @@@ Daniel Hsiang-Te Tsai, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1658474###Co-Author###PhD student###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Daniel Hsiang-Te Tsai, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1358157###Co-Author###Associate Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/his
Association of Oral Direct-Acting Antiviral Therapy with Development of Parkinson's Disease in Patients with Chronic Hepatitis Virus

Pilar Hernandez-Con, MD, MSCE – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida ### 1062901###Presenting Author###PhD student###Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida###
Presenting Author: Pilar Hernandez-Con, MD, MSCE – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
### @@@ Raj A. Desai, PhD – Analysis Group ### 1063320###Co-Author###PhD candidate###Analysis Group###
Co-Author: Raj A. Desai, PhD – Analysis Group
### @@@ Haesuk Park, PhD – Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida ### 1357943###Co-Author###Associate Professor###Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida###
Co-Author: Haesuk Park, PhD – Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
###
Associations between HLA variations and serological response to COVID-19 vaccination: an analysis of UK Biobank antibody survey data

Junqing Xie, MBBS, MSc, DPhil – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358612###Presenting Author###DPhil Candidate & Research Assistant###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Presenting Author: Junqing Xie, MBBS, MSc, DPhil – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Beatriz Mothe – HIV Unit-Infectious Diseases Department, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, CIBERINFEC, Spain ### 1991590###Co-Author######HIV Unit-Infectious Diseases Department, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, CIBERINFEC, Spain###
Co-Author: Beatriz Mothe – HIV Unit-Infectious Diseases Department, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, CIBERINFEC, Spain
### @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###
Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his